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Implication of brain cd&! and MAP2 kinases in the phosphorylation of
tau protein in Alzheimer’s disease 
Rcccivcd 23 June 1992 
Brain mu protein is phorphorylatcd in vitro by de? and MAP:! kinillsc% obteimd through immunouITinily purification from pIlt brain extracts. 
The phosphorylation ritn xc loctitcd on IIK IYI’ rxlceuic both uprtrcam aad downrlrwm of the tubulinsbinding motifs. A synthetic pcptidc 
comprirla~ r&duo lQCll3 of the tau ~;cq~ncc. which contains the cpitopc rceognizcd by the monoclonal antibody tnu.1, is aIs4 efficiently 
phosphurylatcd in vitro by cdcl and MAP2 kinars, Phasphoryl;ltion oftl5 llcptidc m;lrkcdly rcduccr its intcruction with the antibody tau-I, as 
it has been dcscribcd for hu protrin in Alzhcimsr’n diticau. Both rdc? and MAP:! kinascr arc present in brain extracts obtained from Alrhclmcr’s 
d&c; paticna. Intcnstingly, the level of cdQ kinasc m;ly bc incrcassd in plicnt brains as compared with non-dcmcnrcd controlx, Thcrc results 
suggest a role for cdrl and MAP? kinascs in phor;phoryl:iting tuu protein II the tau.1 cpilopc in Alxhcimcr’r discarc. 
Tuu pro&: Microtuhulc.;lrsociatcrl protein: Praline-directed protein kinar: Alxhcimcr’s dimbc 
1. 1NTRODUCTlON formtltion in neurons showing the earliest dcgcncrativc 
chongcs [11,22]. 
Senile dementia of Alzhcimcr’s type (AD) is chtlruc- 
tcrizcd by the massive accurnulrrtion of abtrriint strut- 
tures including ncurofibrillnty ttlnglcs (NFTs) in the 
patient’s brains [I]. NFTs urc derived from intrancu- 
ronnl inclusions consisting of tlggrcgatcd paired hclicul 
filamcnu (PHFs). which contain ns n major core corn= 
poncnt a modified form of the microtubulc-associated 
tnu protein [2], This PHF tnu is less soluble. higher in 
molecular wcighr and more acidic than norm4 microtu- 
bulc-associated tau [3-51. PHF tuu also displays irnm 
munorcnctivity for certain entibodics recognizing 
phosphorylotcd cpitopcs 15-l I] and shows a diminished 
binding to the monoclonul antibody tau-I, which reacts 
with u phosphorylrrtion-sensitive cpitopc [ 121. Thcsc dis- 
tinctive features of PHF ttiu urc due to its abnormally 
hypcrphosphorylatcd state with resprct o that of nor- 
mal tau [2-15]. 
Thus, there is a great intcrcst in clucidrrting the pro- 
rein kinascs implicated in tau hypcrphosphorylation i
AD. An important clue is provided by the fact that 
several Scr/Thr-Prrt scquenas on tau protein urc found 
phosphorylntcd in PHF tau [4,10,23]. Likewise. the 
phosphoryltltion of tau protcii? by prolinc-directed pro- 
tcin kintrse (FDPK) activities present in wll extracts 
1241, brain cytoso1[2§,26] und in brain cytoskclctal [27] 
and tau [28-303 preparations has been dcmonstratcd. In 
this report WC unalyzc the phosphorylation of tau, 
mainly ut the tau-1 cpitopc, by two well-known PDPKs, 
cdc2 and MAP2 kinnscs, which wcrc isolntcd from rat 
brain cytosol, and cxaminc their prcscncc in cxtrtlcts 
from AD ptlticnt brains. 
2. MATERIALS AND METHODS 
The major role for tau protein in normal neurons may 
bc the stabilization of microtubulcs [l&17]. mainly 
within axons [18,191. The binding of tau to microtubules 
is thought o bc modulsrtcd by tau phosphorylation [20], 
Hypcrphosphorylation of tau protein might thcrcforc 
cousc the disorgirllization of the microtubulc ytoskclc- 
ton, blocking axomrl trunsport, in addition to allow the 
deposition of hyperphosphorylatcd tuu into PHFs, thus 
leading to ncurodegcncration, Support& of this view 
is the fact that tau hypcrphosphorylntion prcccdcs NFT 
C’orrespo~~(crrcc arfrl e~M.D. Lcdcsmil, Ccntrd de Biologia Molccu- 
lar(CSIC~UAM), Univcrsidad Autbnoma, %049 Mudrid. Spain. hx: 
(34)( I)397 4799. 
Monoclonrl antibody tuumI [l&31] was a gcncrouv gin of Dr. L-i. 
Binder (University of Alabama). Polyclonnl tlntibodics ayuinrt the 
C-tcrminur of ~34 cdcl [X,33] were gilIs of Dr. P. Nurse (Uniwsity 
af Oxford) and Dr. G. Dractta (EMBL, Hcidclbcrp). A polyclonal 
untibody against the conrcrvcd PSTAIR pcptidc. prcrcnt in cdc2 and 
cd&-like kinascs [34]. was purchuscd from UBI (N.Y.. USA). A mon- 
oclonal antibody to MAP2 kinasc [3S] way purchuvcd fram ZYMED 
Laboratorizr Inc. (Szn Francisco, CA, Ll5A). 
The peptides RSGYSSPGSPGTPGSRSRTP (comprisinp reridurs 
194-213 of the IW rcqucncc), YSSPGSPGTP (comprising residues 
197-206 of the tuu scqucncc), und GTPGSRSR (comprirring rcsiducs 
204-21 I of the tau ssqucncc) were synthesized on an automatic solid 
phusc pcptidc synthcr;ircr (type 430 A, Applied Biosystcms) and puri- 
lied by reverse-phase HPLC on a NOW Puk Cl8 column. Dcphdcs 
wcrc coupled with bovins wrum ztlbunlin (i3SA) using &futardistdc- 
hydc ar cros!+linkcr. 
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Tuu was purifkd from bcrvinc brain microtubules tucerding to the 
prxcdurc of Hcnog und Wcbcr [36]. 
2.3. P rurriu k4hx~x 
Protein kinam wcrc obtained throuyh immuno.vdsorplion Mscn- 
thlly us described by E3oulton and Cobb [37]. The antibody to the 
C+rrminus of ~34 cdQ provided *# Dr. Nurse WYS used IO prcprc 
cdc2 kinusc from S&y-old raf pup bnin CX~MCIII.. Extracts frem adult 
rat brain were used us tt source IQ prclwrc MAP2 kimtrc. Protein 
kinrscs wcrc assayed using 5OpM [y.xP]ATPund cztlfthymux hinonc 
HI or WI brain MAP2 UI rubstralcs. 
The phouphoryhtlon of tuu (20 ~0) w&h cithcr cdc2 or MAP2 
kina- was asrformcd for I h UI 37% in 50 mM Trir.HCI. aH 7.5. -. -- .-. 
2 mM EGTA. 5 mM MaCI: nnd 50pM (y.‘:P]A?P. Pharphorylntion 
reactions wcrc stopped by IIIC addition of boiling SDS sample bulTcr. 
Phorphoryhlion of the synthetic pcprida w;rsrnrrird oul under the 
conditions described for KIU phorphorylntion, c~ecpt hat 3 h of incu. 
bntion ELI 37% was used, Phorphoryhtcd pcptidc was spamtcd from 
ATP by rcvcrsc.phasc llromrrld~ruphy on I Navu Pack Cl8 column 
equilibrated with 0.1% trifluara#cctic acid in water and clutcd using 
zt linear grudicnt of O-80!% ucc~dnilrilc in 0.1% trifluordxctic acid. 
The pharphorylrlion of the liynthctic pptidc conjuptcd with BSA 
was performed for 3 h iit 37.C in 50 mM Trir+lCI. pH 7.5: 2 mM 
EGTA. 5 mM MgCI: and 5 mM ATP. Phorplroryl~tion WIAP stopped 
by the addition of boiling SDS sttmplr buffer. 
SDS.polyttcryl;~midc gel clcctrophorcrir WUJ performed xcerding 
to the proculurc of Lucmmli [38]. Phorpholnbcled proteins wcrc dc. 
tcercd by uutondidgraphy of dried pcls cxpoxcd ICL Kod;rk.X.Omat 
films. 
2.6. Qsirirrc-spcc$r ctwrid cfwmiffr uf ftitf pwcirr 
Phosphorytutcd tiIu protein bonds wcrc cxcircd from the gels. cquil. 
ibrutcd in 0.1 M Trir-HCI. pH 1.0, mcthsnol (50% v/v) und trcaud 
with 2 mM l.nitrd.5~lhiocyanobcnwoic acid (NTCB) disrolvcd in 7.5 
M urcti. 0,2 M T&MCI. I mM EDTA. pH U,O. as dclscribcd bcforr 
(271. 
Phosphorylutcd pcplidcr wcrc lrydrolyxd with 6 N HCI Tar 4 h at 
I IO*C. Pharphoamina acids were scpiirutcd by onc.dimcnrionrl clcc. 
rrophcmsir on ccllul~rc thin layer using acetic acid.!pyridinc/wutcr 
(50:5:9JS) at 900 V [or 60 min. 
!Xstmplcs wcrc cithcr clccrrophoracd an SDS.polyrcrylnmidc gclr 
and tnnrfcrrcd to nitroccllulosc prlpr or directly doltcd onto nitrsccl- 
lulorc paper and prdotd with antibodies. Immunorcxtivc protcinr 
wcrc visunlizcd by the USC of pcroxidusc.conjug;ltcd or alkaline phor- 
phatarceonjuptcd secondary untihodicn. 
Sampler from temporal cdrtc% prny mutter from brains from three 
AD or ugc-matched non-dcmcntcd subjects wcrc collcctcd after short 
post.mortcm periods and frozen in liquid nitrogen. To prcpsrc the 
extracts, samples wcrc thnwcd, homogcnizcd in 50 mM Tris-HCI pH 
7.5; 2% SDS and ccntrifugcd al lOO,OOO x I: for I h, Aliquotr of the 
supcrnatanls containing the same amount of prdtcin were churactcr- 
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Fig. I. Phorphotylrtion of tuu protein by cdc? nnd MAP2 kinuscs. 
Uovinc bruin tau war phorphoryllrlcd in vitro bycirhcrcdclor MAP2 
kinrrr and subjected IO SDS-ycl clcclrdphorcsir and uutorzdiognphy. 
(A/ fhc uutorrdiapram shows tuu prohzin bands phosphorylutcd by 
cdc2 kinrrsc nnd numbcrcd in order af incrcarinl mdlcculnr weight 
(left). The NTCB phorphopcptidc mrpr of thwc tw protein bandsarc 
shown in the autontdiogrrphy to the right. The positionr af unclcavcd 
t;ru.und of the N.tcrmin;rl and C-tcrminrl fr&gmcnt;urc indicated.(B) 
The uulorndidgnm shawr IIU protein band phorph :;latcd by MAP2 
kinuse (left). The corrcrponding NTCB phosphopcrlidc mupr of thcr 
luu prolcin bands urc shown lo the right. 
3. RESULTS 
Both cdc2 and MAP2 kinascs. obtuincd through im- 
munoaffinity purification from rat brain extracts, phos- 
phorylatc bovine bruin tau protein. In our clcctro- 
phorctic system, bovine brain tslu is rcsolvcd into four 
intcnsc bands. till of which arc phosphorylntcd by thclsc 
protein kinascs (Fig. 1). Thcsc results arc consistent 
with the previously rcportcd phosphorylation of tau by 
a PDPK present in rat brain cytoskclctal pro&a prcpa- 
rations obtained in our laboratory [27]. This PDPK 
actually corresponds to MAP2 kinasc. which is associ- 
ated with microtubules (unpublishsd results). 
The distribution of phosphorylation sites on tau mol- 
ccule was studied after cysrcinc-specifts chcmisal clcav- 
age by S-cyanylarion using NTCR. The NTCB 
phosphopcptidc maps obtnincd for tau protein 
phosphorylatcd by cdc2 or MAP2 kinases show that 
both amino- and carboxy-terminal fragrncnts arc 
phosphorylatcd (Fig. I). Dcnsitomctric scanning of the 
corresponding autoradiopraphics suggests the prctxncc 
ofmorc than three phosphorylation sites on the amino- 
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Fig. 2. Marking of the tau-I cpilogc aficr phozphotylation by cdc2 and MAP3 kinarcr. (A) The synlhctic pplidc Pl bearing rhc rru*l cpitopc 
WIL phorphorylatcd by cdc2 kinasc and purified by MDLC. Absorbance at 275 nm of Ihc clurcd pplidc is shown k-) to@thcr with rhc 
radioactivity (-m) asrociatcd with the pcpridc peak. tnsct shows the phosphoamino ucid analpl of the phorphorylnbxl pcptidc. (i3) The synthcGs 
peptide Pl beuring the tru.1 cpilopc was phorphorylalcd by MAP2 kinusc and rnalyxcd as drrcribcd in A. (C) lmmunobloltiug ;urily rhowiq 
Ihc masking of tati. cpitopc uhcr photphorylotion. Aliquolr (20 py) of bovine brain IRU prorrin CTAU), unphorphorylatcd pcplidc Pl coupled 
with RSA (PI&SA.controI), peplidc PI coupled with BSA and in vitro phosphoryhucd bycdc? kina~(Pt4SA.cdcl K) pcplidc PI coupled with 
BSA and in vitro pkorphorylrtcd by MAP2 kinusc (PI-BSA. MAP2 K) and &ISA (l3SA) wcrc probed with monoclonul antibody tau.l afbzr Wcrlcrn 
blotting. Numbcrr lo the righl indicate the position of molecular weight markcrr in kDa. 
terminal fragment per phosphorylation site on the car- 
boxy-terminal fragment. WC hove previously dcmon- 
approximately ocated within the Pro-rich region of tou 
molcculc 1401. WC have dctcrmincd that a synthetic pep 
strarcd that a synthetic pcptidc corresponding co a tu- tide (P1 = 
bulin-binding motif is not phosphorylatcd by PDPM 
RSGYSSPGSPGTPGSRSRTP) comprising 
[27]. Thus, phosphorylation sites for cdc2 and MAP2 
rcsiducs 194-213 of the tau scqucncc bears chc tau-l 
kinascs must be located both upstream and downstream 
cpitopc, us it is recognized by the monoclonal antibody 
of the repeated tubulin-binding motifs on tau molcculc. 
tau-1 in dot-blor assays and it totally competes with cau 
proccin for nntibody tau=l binding. Shorter synthccic 
This is consistent with the presence of putative ScrTThr- pcptidcs (P2 = YSSPGSPGTP; P3 = GTPGSRSR) arc 
Pro targccts for cdc2 and MAP2 kinnscs on tau. There 
arc four Scr-Pro and ten Thr-Pro putative targets on 
weakly recognized by mu-l in dot-blot assays but arc 
the amino-tcrrninal fragment, whcrcas there arc only 
practically unable to compete with tau protein for tau- 1 
binding (not shown), which suggests an influence of the 
three Scr-Pro putative targets on the carboxy-terminal 
fragment of rau. 
conformation of chc pcptidc in its immunorcactivity 
against he antibody tau-1. 
Of particular elevance is the clustering of most put+ 
tivc phosphorylarion targets at a praline-rich region 
immediately upstream of the tubulin-binding motifs, as 
the conformation of this region. also present in MAP2 
and MXP4, is thought to affect tubulin-binding [39]. 
The synthetic pcpcide bearing the tau-1 cpiropc (pcp- 
tide P1) is cfficicntly phosphorylated by both cdc2 and 
MAP2 kinascs (Fig. 2). Phosphorylation mainly occurs 
at thrconinc, although some scrinc is also modified (Fig. 
2 insets). 
3.2. Phospkorylarion of a synthetic pepeide beuritrg rite 
tall-1 epitopc by c&2 ad MAP2 kituses 
The epiropc for the monoclonal antibody tau-l, 
which is masked upon phosphorylation in AD [12], is 
Pcpcide Pl coupled with bovine serum albumin (Pl- 
BSA) is also cfficicntly phosphorylarcd by both cdcl 
and MAP2 kiaascs. Interestingly, the pcptidc P1 cou- 
pled with BSA reacts with antibody rau-l in im- 
munoblot assay, as expected, and this reaction is almost 
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Fig. 3, Prrsmcc of cdc2 rrnd MAP2 kinnscs in human brain extracts, Brain extracts from ags-matched AD paticnto and control non-dcmcntcd 
rubjwr wrc obtnincd as dcscribcd in ssction 2 and prow with rntihadics to c&2 kinnr We2 K) nnd MAP2 kinarc (MAP2 K). Numbcn to 
the Icft indiE;ltc the positions of malccular wcighl rnrrkcn in kRa. 
rlbolishcd after phosphorylotion by either cdc2 or 
MAP2 kinuscs (Fig. 2). Thus. both cdc2 and MAP2 
kinasrs arc ublc to phosphorylutc and mask the tau-1 
cpitopc. 
3,3. Pt*mvm @c&Z utrd hfAP2 kirtuscs t’tt AD hruirr 
Bcctrusc of their possible implication in phospho- 
rylnting the tau-1 cpitope. WC huvc tested for the prcs- 
cncc of cdc2 rnd MAP2 kinascs in ndult human brain 
extracts from control nonmdcmentcd und AD ptlticntu. 
Fig, 3 shows that both kinzxs ilrc prcscnt in AD bruin 
extracts ubjected to SDS-PAGE and immunoblotting. 
Whcrcas the lcvcl of MAP2 kinnsc is high and similur 
in AD and control human brnin. cdc2 kinasc, which 
does not seem to be as abundant us MAP2 kinasc, is 
more prominent in AD brain th in control human 
brain (Fig. 3). This cdc2 kinrrsc is recognized by three 
diffcrcnt untibodics, two of them raised against he C- 
terminus of p34 cdc2 (the generous gifts from Dr. Nurse 
and Dr. Dmctto) and a third raised against he synthetic 
pcptidc PSTAIR. Fig. 3 shows the immunoblotting with 
one of the antibodies to the C terminus of p34 cdc2. 
4. DISCUSSION 
Cdc2 and MAP2 kinascs arc thought to play major 
roles in regulating cell growth and diffcrcntiotion 
through the phosphorylation of a variety of proteins 
which may include components of the cytoskelcton [41- 
431. 
Thus, diffcrcnt forms of cdc2 kinasc have been impli- 
cated in the control of DNA replication and mitosis in 
proliferating cells [41,42], In particular, the mitotic form 
of cdc2 may rcgulrrlc the formation of the mitotic spin- 
dle [44]. possibly through the phosphorylotion of ccr- 
tain MAPS including MAPlB and MAP4 [45,46]. How- 
ever, cds2 kinasc is also present in diffcrcntiatcd PC12 
cells exhibiting o neuron&like phenotype [33] ond in 
youns postmitotic ccrcbcllar neurons at the time of 
neuritc outgrowth [47]. Terminal dif’fcrcntiation ofncu- 
rons is accompanied by down-Lxgulntion of cdc2 [43], 
This sqgcsts P role for cdc2 during the corly stages of 
ncuronal morphogcncsis. 
There arc also different forms of MAP2 kinasc, rc= 
ferrcd to as ERKs (cxtrrrccllular rcgulatcd kinoscs), 
which arc ERKl (p44 MAPK), ERK2 (p42 MAPK), 
ERK3 and ERM4 [43]. Similarly to cdc2, ERKs may 
also participate into mitotic regulation [48], presumably 
acting on MAPS [46,49], In contrast to cdd. the level 
of ERKs increases during rat brain dcvclopmcnt [SO]. 
The activity of ncuronal MAP2 kinasc can bc regulated 
in response to certain ncurotrophic factors [50,51] and 
ncurotransmittcrs [S2]. It is plausible that MAP2 kinasc 
is the main PDPK present in adult mammalian brain. 
The relationship. if any, of either cdd or MAP2 kinascs 
with other PDPKs detected in brain i25-301 has not 
been addressed. 
Our results show that cdc2 and MAP2 kinascs, iso- 
lated from rat brain extrxts, may phosphorylatc tau 
proteins at the tau-1 cpitopc and that those kinascs arc 
present in AD brain. MAP2 and MAP4, two proteins 
bclonginp to the same MAP superfamily as tau [39], 
have also been dclicritxd as in vitro substrates for both 
cd& [45,53,54] and MAP2 kinases [49.§5]. It has been 
shown that the substrate spesificitics of&2 and MAP2 
kinascs partially overlap in vilro and that, at least in the 
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cast of nuclear tnmin, phosphorylution occurs at A com- 
mon site [56]. This suygtits the possibility of coopera- 
tion bctwccn cdc2 and MAP2 kinascs in phosphorylut- 
ing common subsmtcs. which may hc particularly im= 
porcant to rlmplify the dcgrcc of phosphorylacion of 
abundant cycoskclctul proteins, Howcvcr, it still rc- 
mains unclear chc extent of the ovcrlnp in substrate 
specificities between cdc2 and MAP2 kinascs in vivo. 
An importunc f%ctor in this respect could bc the modu- 
lation of chc substrate spccihcity displayed by the catn- 
lytic p34 cdc2 in rcsponsc to its binding to cyclins which 
act as regulatory subunits [41.57]. There arc several 
types of cyclins, referred co as A, B, C. D and E [58], 
but their precise influcncc on the substrate specificity of 
p34 cdc2 is not fully undcrscood, On the ocher hand, 
nothing is known about the cyclin subunits which prc- 
dominutc in brain and arc complcxcd with ncuron~l p34 
cdc2 and related kintiecs. 
A point of major concern is the regulation of CPU 
phosphorylation at chc cau- 1 cpicopc in vivo. both under 
physiological conditions and in AD. In adult rut brain. 
cou proccin dcphosphoryluccd at the tau-1 cpicopc is 
confined to axons. whereas tau protein phosphoryloted 
at the tau-1 cpitopt is present in ncuronal cell bodies 
and dendrites [31]. If WC assume that MAP2 kinasc is 
the main PDPK able co phosphorylucc the kru- 1 cpitopc 
in adult rat brain, this would sufigcst a prcdominoncly 
somacodendritic compartmcncation f the enzyme. Cu- 
riously. the muin in vitro substrate for MAP2 kinasc is 
MAP2, which shows a strict somutodcndritic compart- 
mcntntion f59-611. This might indicate a putative intsr- 
action bctwccn MAP2 and the kinuse, which is sup- 
ported by the fact chat MAP2 kinusc is indeed prcscnc 
in microtubulc preparations (unpublished results). 
In AD, most cau becomes phosphorylaccd atchc tau-1 
cpitopc [12]. This may bc a conscqucncc of a failure in 
the phosphatascs acting at chc tau-I site. an ovcr-activa- 
tion of MAP2 kinascs andfor an up-regulation of cdc2 
kinascs. Our results howing the prrscncc of cdc2 and 
MAP2 kinascs in AD brain support the latter possibili- 
ties. The up-regulation of cdc2 kinasc does not seem to 
be unique, as a rc-expression ofwrtain proteins charac- 
cristic of the ftial brain after agcing, and particularly in 
AD brain, has been previously described [62,63]. This 
may bc hypothcticnlly connected with the massive and 
aberrant ncuritc rcgencration suppossdly associated 
with AD [63]. 
Clearly further research on the signal transduction 
mechanisms controlling the expression and activation 
of cdc2 and MAP2 kinnscs in neurons is required before 
understanding their alterations in AD. Some in vitro 
snd animal models may bt useful in this rcspccc. For 
instance, ccrcain PKC activators, which also enhance 
MAP2 kinusc activity in cultured cells [64], trigger chc 
appcarancs of immunorcactivity for antibodies rccog- 
nizing PHF-tau in cultured human corticn) neurons [65]. 
Likewise, heat shock, which induces a form of cdc2 
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kinusc in cultured cells [66). also results in the hypcr- 
phosphorylation of tau proccin at the tnu-I epicopc in 
rat brain [67]. 
Finally, the functional conscqucnccs of tau phospho- 
rylation at chc tau-1 cpitopc should bc considcrcd, 
Phosphorylation of the Pro-rich rcyion of tau molecule 
may diminish its binding :a tubulin, as it has been re- 
ported for other MAPS, such as MAP2 and MAP4 [49]. 
This might bc one of the events leading to the reduction 
in tubulin binding-compctcnt tau and the subsequent 
disorganiwtion of the microtubulc ytoskclcton which 
arc obscrvscl in AD. 
Acd;rtrn~/~~~~:Nlmrrr: WC arc gnlfcful 10 Dr. LA Oindcr (Uniwrcily of 
Alubumn) for rhc gift ofurtibody tau-I, and Dr. G. Dract13 (EMBL, 
Hcidelbcrgl olrd Dr. I? Nurrc (Uniwrsity aTOxford) for the Sifts of 
antibodies to ~34 cdr2. WC ;rlra thank Dr. C. Wirhik (Bruin Bank, 
Cambridge) for providing normal und AD bninr, Thir work was 
%upponcd by B arunt from Sp:mish CICYT (PD9&00%7) mnd an inrti. 
tutionul prum from Fundnri6n R;lnkm Arcccr. 
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A Compatanca assay 
B Dot-blot assay 
Tau PI-BSA PI 
AppcndiK I, Binding or rynlhctic pcpfidcr to m~~rorlon~~l antibdy 
w-l. A, Compcrcncc n~iby bctwccn tau pro~;r~ and synthetic pep- 
tidcr for twl binding. Snmplcr oTJ~M pcp~idcr PI, P3 und PZ arc 
incubiltcd with untibody rau-I diluted 1:10,000 ovcrrright. Then thcrc 
rumplcr wcrc incutxrtcd with I pg of MI protein prcviausly dotted 
onto nitroccllulorc paper. Dcnrkomctric dura urc rcprcscnlcd as hi*@ 
grnmr, fn the control cxpcrimcnt, unfibdd)l ~uu-I *ithou! any peplidc 
wax used. l3, Dot-blot ersuy showing the binding of qallrctic p+idc 
PI to untibady t;a,~~ I. Antibody luu- 1 diluted 15.000 was prabcd wit!r 
0,3 /rg crf tnu protein. pcplidc PI coupled with USA and pcpiidc PI 
August I992 
cdc2 K cdc2 K 
4nfi-PS?AIR Anti-C 
MAP2 K 
Appendix 2. Prcrcncc of cdc2 clnd MAP2 kinascs in humnn brain 
QWJC~X. Urnin cxtracIT from ugc-mntchcd AD pnlicntr und control 
nan-dcmcnfcd subjects wcrc obtrincd PI dcscribcd in wtion 1 and 
rrubjcctcd to gel clwrophorcsis and immunoblolting. Blots wcrc 
prabcd with two :mlibadicx to cdcl kinare (cdc? K), OIIC rccogniwing 
n common scrp~rncc racdcl nnd cd&like kinrrcr (rnW5TAtR)and 
nnorhcr rccognixing rhc C terminus of rdcl kimroc (anli-CL imd one 
nnlibody !o MAP? kin;w (MAP? K). 
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